药物性帕金森综合征（DIP）管理的最新观点：来自临床的见解
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.
作者信息
Feldman Matthew, Marmol Sarah, Margolesky Jason
机构信息
Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
出版信息
Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022.
Abstract
Parkinsonism refers to the clinical combination of bradykinesia, rigidity, tremor, and postural instability. Parkinsonism is often neurodegenerative, but it can be secondary or iatrogenic, as in drug-induced parkinsonism (DIP), which is the topic of this review. We review the pathophysiology of DIP, differentiate DIP and idiopathic Parkinson's disease (PD), list culprit medications in the development of DIP, discuss the diagnosis of DIP as well as the motor and nonmotor signs and symptoms that can help with differentiation of DIP and PD, and detail the management of DIP.
摘要
帕金森综合征是指运动迟缓、肌强直、震颤和姿势不稳的临床组合。帕金森综合征通常是神经退行性疾病，但也可能是继发性或医源性的，如药物性帕金森综合征（DIP），这是本综述的主题。我们回顾了DIP的病理生理学，区分了DIP和特发性帕金森病（PD），列出了导致DIP的罪魁祸首药物，讨论了DIP的诊断以及有助于区分DIP和PD的运动和非运动体征及症状，并详细介绍了DIP的管理。
相似文献
1
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.药物性帕金森综合征（DIP）管理的最新观点：来自临床的见解
Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022.
2
Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism.帕金森病与帕金森综合征鉴别诊断的临床要点
J Clin Neurol. 2022 May;18(3):259-270. doi: 10.3988/jcn.2022.18.3.259.
3
Drug-induced parkinsonism.药物性帕金森病。
J Clin Neurol. 2012 Mar;8(1):15-21. doi: 10.3988/jcn.2012.8.1.15. Epub 2012 Mar 31.
4
Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.并非所有药物性帕金森综合征都相同：药物类别对运动表型的影响。
Neurol Sci. 2017 Feb;38(2):319-324. doi: 10.1007/s10072-016-2771-y. Epub 2016 Nov 16.
5
Drug-induced parkinsonism: diagnosis and treatment.药物性帕金森综合征：诊断与治疗
Expert Opin Drug Saf. 2024 Dec;23(12):1503-1513. doi: 10.1080/14740338.2024.2418950. Epub 2024 Oct 25.
6
Drug-induced parkinsonism in the elderly: incidence, management and prevention.老年人药物性帕金森病：发病率、治疗和预防。
Drugs Aging. 2012 Feb 1;29(2):105-18. doi: 10.2165/11598540-000000000-00000.
7
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.[123I]-FP/CIT单光子发射计算机断层扫描成像用于区分药物性帕金森综合征与帕金森病。
Mov Disord. 2006 Apr;21(4):510-4. doi: 10.1002/mds.20748.
8
Drug-induced parkinsonism.药物性帕金森病。
Curr Treat Options Neurol. 2009 May;11(3):162-9. doi: 10.1007/s11940-009-0019-3.
9
Parkinsonism in the psychiatric setting: an update on clinical differentiation and management.精神科环境中的帕金森综合征：临床鉴别与管理的最新进展
BMJ Neurol Open. 2020 Jan 27;2(1):e000034. doi: 10.1136/bmjno-2019-000034. eCollection 2020.
10
Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.经颅超声表现可能预测促胃肠动力药物相关性帕金森综合征的预后。
Parkinsonism Relat Disord. 2018 Jan;46:36-40. doi: 10.1016/j.parkreldis.2017.10.011. Epub 2017 Oct 19.
引用本文的文献
1
Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism.探索药物性帕金森综合征中与海马亚区萎缩相关的认知和情绪症状。
Front Aging Neurosci. 2025 Jul 9;17:1566785. doi: 10.3389/fnagi.2025.1566785. eCollection 2025.
2
Drug-Induced Parkinsonism or Parkinson's Disease: A Diagnostic Challenge in a Psychiatric Patient.药物性帕金森综合征或帕金森病：一名精神科患者面临的诊断挑战
Cureus. 2025 Jul 17;17(7):e88177. doi: 10.7759/cureus.88177. eCollection 2025 Jul.
3
Neuroimaging Techniques in Differentiating Parkinson's Disease from Drug-Induced Parkinsonism: A Comprehensive Review.神经影像学技术在鉴别帕金森病与药物性帕金森综合征中的应用：一项综述
Clin Pract. 2023 Nov 15;13(6):1427-1448. doi: 10.3390/clinpract13060128.
4
Overview of Movement Disorders Secondary to Drugs.药物所致运动障碍概述
Clin Pract. 2023 Aug 18;13(4):959-976. doi: 10.3390/clinpract13040087.
本文引用的文献
1
Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism.步态异常和非运动症状预示着疑似药物性帕金森综合征患者多巴胺能成像异常。
NPJ Parkinsons Dis. 2022 Apr 28;8(1):53. doi: 10.1038/s41531-022-00309-8.
2
Clozapine-Induced Hypersalivation Treated with Sulpiride - Is It a Solution?舒必利治疗氯氮平引起的唾液分泌过多——这是一种解决方案吗？
Psychiatr Danub. 2021 Spring;33(Suppl 4):1230-1232.
3
Use of antipsychotics and long-term risk of parkinsonism.抗精神病药物的使用与帕金森病长期风险的关联。
Neurol Sci. 2022 Apr;43(4):2545-2553. doi: 10.1007/s10072-021-05650-z. Epub 2021 Oct 15.
4
Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies.抗精神病药引起的锥体外系副作用：观察性研究的系统评价和荟萃分析。
PLoS One. 2021 Sep 10;16(9):e0257129. doi: 10.1371/journal.pone.0257129. eCollection 2021.
5
Valbenazine-induced parkinsonism.缬苯那嗪诱发的帕金森综合征。
Parkinsonism Relat Disord. 2020 Jan;70:13-14. doi: 10.1016/j.parkreldis.2019.11.021. Epub 2019 Nov 25.
6
Substantia Nigra Echogenicity Predicts Response to Drug Withdrawal in Suspected Drug-Induced Parkinsonism.黑质回声可预测疑似药物性帕金森综合征患者对药物戒断的反应。
Mov Disord Clin Pract. 2015 Dec 18;3(3):268-274. doi: 10.1002/mdc3.12281. eCollection 2016 May-Jun.
7
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism.嗅觉障碍预示着疑似药物性帕金森综合征潜在的多巴胺能缺陷。
Mov Disord Clin Pract. 2016 Nov 28;4(4):603-606. doi: 10.1002/mdc3.12458. eCollection 2017 Jul-Aug.
8
DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.在专业运动障碍门诊中，药物诱导的帕金森病病例的 DAT-SPECT 成像。
Parkinsonism Relat Disord. 2018 Aug;53:37-41. doi: 10.1016/j.parkreldis.2018.04.037. Epub 2018 May 5.
9
Tacrolimus-induced parkinsonism in a patient after liver transplantation - case report.肝移植术后他克莫司诱发帕金森综合征——病例报告
BMC Neurol. 2018 Apr 20;18(1):44. doi: 10.1186/s12883-018-1052-1.
10
Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.更新迟发性运动障碍治疗建议：新证据的系统评价和实用治疗算法。
J Neurol Sci. 2018 Jun 15;389:67-75. doi: 10.1016/j.jns.2018.02.010. Epub 2018 Feb 5.
Zotero 插件